It could also help prevent and treat Alzheimers disease and other age-related mental health conditions and dementias
TNF-alpha, interleukin-6 (IL-6), interleukin-1-beta (IL-1B), and interferon-gamma (IFN-gamma) drive persistent inflammation that damages tissue over time
Specialized clientele attraction: Appeal to clients with hyperpigmentation, melasma, and skin lightening goalshighly motivated, committed market
In the published literature, afamelanotide is studied as an agonist at melanocortin receptors, principally the melanocortin-1 receptor (MC1R), within in-vitro systems and pre-clinical models
There are also microbial contamination concerns with refillable vessels over time
It helps reduce oxidative stress and protects skin cells from damage, contributing to a brighter complexion and reduced pigmentation